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Abstract
S. Typhi is an enteric bacillus which belongs,to the genus Salmonella in the 
family Enterobacteriacaea and it is a multi–organs pathogen which inhibits the 
lymphatic tissues of the small intestine, liver, spleen, and blood stream of infected 
humans.S.Typhi has a mixture of features that make it an efficient pathogen. This 
species contains an endotoxin that is characteristic of Gram-negative organisms, as 
well as the virulence-enhancing Vi antigen. Many of the S. Typhi virulence factors 
are clustered in some areas of the chromosome known as Salmonella pathogenic-
ity islands (SPI), such as adhesion, invasion, and toxin genes. A protein known 
as invasin that permits non-phagocytic cells is also produced and excreted by 
the bacterium., Where it is capable of intracellular living. The oxidative burst of 
leukocytes may also be inhibited, making innate immune reaction ineffective.
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1. Introduction
It was quite a long time before typhoid fever was differentiated from other febrile 
disorders. Pierre Louis was the first who used the word “ typhoid “ and give the classical 
picture of typhoid in 1829 and described in detail post-mortem finding, especially the 
enlargement and ulceration of peyer’s patches. However, he did not clearly differentiate 
between typhoid and typhus. In 1837,Gerhard was the first who clearly differentiate 
typhoid from typhus fever and William Budd described the contagious nature of the 
disease and Incriminated transmission of facially polluted water supplies in 1873 [1].
In 1873, William Budd, a physician in Bristol who was interested in cholera and 
intestinal fever, showed that typhoid fever could be transmitted by a particular toxin 
found in the excrement and that this propagation was responsible for the contamina-
tion of water by the feces of patients. Each case was linked to another anterior case, 
according to Budd. A significant number of doctors and scientists have attempted 
to discover the nature of the disease-causing microorganism and have experienced 
considerable difficulty in isolating the bacillus. It was Karl Joseph Eberth, Rudolf 
Virchow’s doctor and pupil, who discovered the bacillus in the abdominal lymph 
nodes and the spleen in 1879. In 1880 and 1881, he reported his findings. The 
genus ‘Salmonella’ was named after Daniel Elmer Salmon, an American veterinary 
pathologist, who was the administrator of the USDA (United States Department 
of Agriculture) research program. His discovery was then tested and confirmed by 
German and English bacteriologists, including Robert Koch., Thus, despite the fact 
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that a number of scientists had contributed to the quest [2, 3], the organism was 
named after him. Salmonella has thus become new scientific knowledge and thus the 
mechanisms of infection and the presence of healthy carriers have been relatively 
nascent [4]. Recent reports suggest that there are approximately 20 million cases of 
typhoid each year, resulting in deaths of 100,000-200,000 [5]. Karl J. Eberth, who 
isolated the bacterium from spleen parts and lymph nodes from a patient who died 
of typhoid fever and discovered the typhoid agglutinins and their diagnostic applica-
tion, first isolated S. Typhi in 1880. In 1881, Robert Koch succeeded in cultivating the 
bacterium. However the isolation of typhoid bacillus from other enteric bacteria was 
unclear due to the lack of differential characters [6, 7].
Salmonella is a genus of rod shaped (bacillus) gram negative bacteria related 
to family Enterobacteriaceae. They have two species which are Salmonella enterica 
and Salmonella bongori. S. enterica is the kind species and is further divided into sex 
subspecies [8]. that contain over 2,600 serotypes [9]. Salmonella species are non 
spore forming, predominantly motile enterobacteria for cell diameters between 
on 0.7 and 1.5 μm, lengths for 2 to 5 μm, and peritrichous flagella (all concerning 
the cell body [10]. exceptions S. Gallinarum and S. Pullorum [11, 12]. The bacterial 
strain was named after the American pathologist, Dr. Daniel Elmer Salmon, who 
collaborated with Smith. The Salmonella nomenclature is controversial and still 
changing. The Centers for Disease Control and Prevention (CDC) is currently using 
the Salmonella nomenclature system suggested by the World Health Organization 
(WHO) Collaborating Centre as a nomenclature system.: Species: Salmonella 
enterica serotype Typhi. [13].
2. Virulence factors of Salmonella Typhi
Virulence factors in Salmonella Typhi are involved in the various stages of infection, 
namely: the production of toxins (LPS) endotoxin, enterotoxin, cytotoxin), coloniza-
tion, adhesion and invasion, as well as survival inside the host cells [14] (Figure 1).
2.1 Vi antigen
The capsular Vi antigen is a linear homopolymer of alpha 1–4 linked to galactose 
aminouronic acid which is variably acetylated at the C3 position. This antigen is 
Figure 1. 
Salmonella virulence factors [14].
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believed to inhibit phagocytosis and complement C3 activation thus inhibiting 
non-specific opsonization, “[15] One of the main characteristics that distinguishes 
S. Typhi from (non typhoid Salmonella) NTS is the production of a polysaccharide 
capsule named the Vi antigen. The Vi capsule inhibits phagocytosis and confers 
serum resistance [16, 17], likely by shielding the O-antigen from antibodies [16]. 
The genes encoding the Vi capsule comprise the viaB locus within Salmonella 
pathogenicity island (SPI)-7, which also encodes the type III secretion system 
(T3SS) effector SopE and a type IVB pilus [18].
2.2 The SPI-1, SPI-2 and type III secretion systems
Common to both typhoidal and NTS are two pathogenicity-island encoded 
type III secretion systems (T3SS): the SPI-1 and SPI-2 T3SS, which are essential 
for Salmonella virulence. In S. Typhi, the SPI-1 T3SS is also required for invasion 
of nonphagocytic cells [19], but the importance of the SPI-2 T3SS is less clear. 
Disruption of the SPI-2 T3SS did not influence the survival of S. Typhi in THP-1 
and human monocyte-derived macrophages [20]; however, S. Typhi strains with 
transposon insertions in the SPI-2 components ssaQ, ssaP, or ssaN were negatively 
selected against during competitive growth in human macrophages [21]. The role 
of SPI-2 during the intracellular lifestyle of typhoidal serovars therefore warrants 
further investigation.
2.3 Somatic O antigen (cell wall Ag or LPS)
The outer L-layer underlying the capsular material has the lipopolysac-
charide (LPS) called the ‘0’ antigen. This’L’ layer also has certain proteins called 
outer  membrane proteins (OMP) which are antigenic. These OMPs include both 
porin (OMP F and OMP C) and non-porin substances. Porins are pore-forming 
channels which help in solute uptake and non-porin proteins are structural 
proteins (Figure 2) [22]. These antigens are highly immunogenic and there is 
a good antibody response to all these antigens in patients with typhoid fever.”. 
[23, 24]. The somatic  antigens represent the side chains of repeating sugar unit 
projecting outwards from the  lipopolysaccharide layer and the surface of the 
bacterial cell wall; they are  hydrophilic and heat stable. It is used for serological 
diagnosis [26].
Figure 2. 
Antigenic structure of Salmonella Typhi [25].
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2.4 Flagella(H antigen)
Flagella, while contributing to virulence, are also important activators of innate 
immune responses via recognition of monomeric flagellin by TLR5 and NAIP recep-
tors [27, 28], H antigen may occur in either or both of two forms, called phase 1 and 
phase 2. The organism tends to change from one phase to the other. H antigen also 
provides a useful epidemiologic tool with which to determine the source of infec-
tion and its mode of spread [29]; While most NTS display phase variation through 
the alternate expression of two genes of flagellin (fliC and fljB), most S. Typhi 
strains are monophasic, expressing FliC of the antigen H: d directly. Interestingly, 
some Indonesian S. Typhi strains transmit H: j, due to an in-frame deletion in fliC, 
a variant of H:d. [30], and/or are biphasic, expressing a plasmid-encoded FljB 
analogue of the H:z66 antigen [31], H:j and H:z66 antigenic variants are thought to 
have recently emerged during S. Typhi evolution [32], driven by immune selection 
in this high incidence region [31]. This additional variation seems to play a role in  
S. Typhi interactions with host epithelial cells and macrophages and partly in 
immune evasion [33].
2.5 Fimbriae (adhesion protein) and pili
The significant adhesion factors for S. Typhi are fimbriae and pili.. These elements 
of virulence are employed by S. Typhi during infection and host colonization for its 
various cellular interactions [34]. The Operon Stg, one of the six Operons Fimbriae 
found in S. Typhi, But not S. Typhimurium has recently been shown to be involved 
in cellular invasion and in vitro destruction of epithelial cells [34]. In addition, the 
STG operon was found to assist S. Typhi targets enterocytes more preferentially than 
M cells, which promotes S. Typhi By passing the Peyer patches, eludes the innate 
immune system [35].
2.6 Virulence plasmid
Certain Salmonella carry a large, low copy number plasmid that contains 
virulence genes. Virulence plasmids are required to trigger systemic disease; their 
involvement in the enteric stage of the infection is unclear. Salmonella virulence 
plasmids are heterogeneous (50–90) kb in size, but all share a 7.8 kb area, SPV, 
necessary for reticuloendothelial system bacterial multiplication [36, 37].
2.7 Invasiveness
Unlike most bacteria that rely on endocytosis mediated by receptors in order to 
invade a target cell, S. Typhi uses a complex mechanism known as bacterial medi-
ated endocytosis, in which bacterial proteins enter the host cell and control signal-
ing cascades that regulate the trafficking of cytoskeletal membrane architecture 
and gene expression, both of which force endocytosis S. Typhi into the host [37, 38]. 
The target cell for S. Typhi is the macrophage. The ability of S. Typhi to survive in 
macrophages is due to the development of bacterial proteins that allow the organism 
to with strand both the oxygen-dependent and the non oxygen-dependent killing 
mechanisms of these professional phagocytic cells [36, 37].
2.8 Biofilm
Biofilm cells manufacture proteinaceous substances that allows synergic growth 
and protection from possible harsh environments it may encounter [39, 40]. In the 
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seventeenth horn, a Dutch scientist Van Leeuwenhoek was the first individual to 
discover biofilm cells which he described as “animacules” on his dental plaque. The 
biofilm development process is initiated with single cells attaching to a surface or to 
each other, this is then followed by the formation of clustered cells or microcolonies. 
Over time, the microcolonies are surrounded by a protective layer of protein-rich 
substances referred to as extracellular polymeric substances (EPS) [37]. The devel-
opment and genetic signaling pathways involved in a Salmonella biofilm formation 
are complex. There are four major components to the structure of the Salmonella 
biofilm: curli, cellulose, capsular polysaccharides and lipopolysaccharides. Curli 
fibers, referred to as thin very aggregative fibers (Tafi) are one of the main compo-
nents of the extracellular polysaccharide (EPS) matrix [40, 37].
Enea,et al.,2017 [41] were found biofilm production by S. Typhi may represent a 
key factor for the promotion of a persistent infection in the gallbladder, thus sustain-
ing a chronic local inflammatory response and exposing the epithelium to repeated 
damage caused by carcinogenic toxins. Figure 3 demonstrates the potential role of 
biofilm-producing S. Typhi, in the development of gallbladder cancer. (A) Chronic 
S. infection. Typhi strains and gallstone presence strongly correlate with the devel-
opment of gallbladder cancer (GC); The presence of gallstones (B) could provide 
Figure 3. 
Showing the potential role of biofilm-producing S. Typhi in the development of gallbladder cancer. (A) Chronic 
S. infection. Typhi strains and gallstone presence strongly correlate with the development of gallbladder cancer 
(GC); The presence of gallstones (B) could provide S. Typhi strains with the ideal substrate. (C) Once the biofilm 
is established, bacterial cells are separated from the gallstones that release carcinogenic molecules [41].
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S. Typhi strains with the ideal substrate. (C) Once the biofilm is established, bacte-
rial cells are separated from the gallstones that release carcinogenic molecules that 
induce genomic instability and chronic inflammation, which are key prerequisites 
for the onset of GC. with an increased biofilm forming capacity.
2.9 Endotoxin of Salmonella Typhi
Endotoxin is a big part of Gram-negative bacteria’s outer membrane (OM). 
Endotoxins have been found to play an important function in the pathogenicity 
of Gram-negative bacterial infections. It is a powerful mediator of a wide range 
of pathophysiological effects in humans, mainly in the gasterointestinal tracts. 
Therefore, these are also known as enterotoxins. These toxic behaviors, as well as 
many beneficial ones linked to immunostimulation, include lethal toxicity, pyro-
genicity and tissue necrotizing activity [42]. Endotoxins are high-molecular weight 
complexes, of lipopolysaccharides (LPS) which is the major component of bacterial 
cell wall [42]. It’s a heat stable toxic substance released by gram negative bacteria’s 
after disruption of cell envelopes [43, 44]. The role of endotoxins in bacterial patho-
genesis and their chemical characterization as lipopolysaccharide (LPS) have been 
studied earlier [45, 46]. Chemically, LPS consist of a hydrophilic polysaccharide 
covalently linked to a hydrophobic lipid portion which is termed as lipid A, which 
anchors the molecules in the outer membrane (OM) [47]. Endotoxins play a major 
role in human disease states that created interest to investigate the pathogenicity of 
the producing bacteria [42]. Lipopolysaccharide found to be an important activa-
tor for the activation of immune system that leads to non- specific inflammatory 
immune response [48].
3. Conclusions
According to above review we put highlights on the role of the Salmonella 
virulence factors. In addition, we mentioned some strategies that could be explored 
in order to take control of Salmonella infections.
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